Session Information
AABB Annual Meeting and TXPO 2009
Click here to go to the previous page
The Bleeding Patient on Anti-thrombotic Therapy: How Should the Transfusion Service Respond?
Track
:
TC-Technical/Clinical
Program Code:
9412-TC
Date:
Tuesday, October 27, 2009
Time:
10:30 AM to 12:00 PM
EST
Location:
383/384
DIRECTOR
:
Kenneth D. Friedman, MD, Medical Director, Hemostasis Reference Laboratory, Blood Center of Southeastern Wisconsin
MODERATOR
:
Kenneth D. Friedman, MD, Medical Director, Hemostasis Reference Laboratory, Blood Center of Southeastern Wisconsin
SPEAKER
(S):
Jonathan Waters, MD, Chief, Anesthesia Services, Magee Womens Hosp. of Univ. of Pitts. Med. Center
Arthur Bracey, MD, Medical Director Transfusion Services, St. Luke's Episocopal Hospital/Texas Heart Institu
Mark Crowther, MD, MSc, FRCPC, Professor, Division of Hematology and Thromboembolism, McMaster University
Description
Transfusion Services are commonly asked to provide advice and/or blood products in order to acutely reverse the effects of antithrombotic therapy. Multiple factors influence the choice of intervention, including the patient's clinical situation, the mechanism of action of the patient's antithrombotic therapy, the extent of antithrombotic effect at the time the patient presents, and whether a specific agent or non-specific agent is available to antagonize the antithrombotic agent. In this session, cases will be used to highlight key issues related to urgent reversal of vitamin-K antagonist medication, management of bleeding or perioperative patients receiving antiplatelet agents, and the use of near-patient testing to guide hemostatic support in the surgical suite.
- Assess the role of vitamin supplementation, coagulation factor concentrates and plasma therapy in the acute reversal of anticoagulant effect.
- Determine the mechanism of action and duration of effect of commonly used antiplatelet therapies, and in which settings platelet transfusion therapy is reasonable.
- Recognize the diversity of near-patient testing techniques used during operative monitoring, and how this data is supporting decisions for transfusion support.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
This session is a part of:
Online Access
(Code: 9412MA/9412NA/9412MN/9412NN)
Attendee/Member:$25 USD
Attendee:$40 USD
Member:$40 USD
$50 USD - Your Price
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |